Article info
PDFPostScript
Letter
O-(2-(18F)fluoroethyl)-L-tyrosine PET for the differentiation of tumour recurrence from late pseudoprogression in glioblastoma
- Correspondence to Dr Constantin Lapa, Department of Nuclear Medicine, University Hospital Würzburg, Würzburg 97080, Germany; lapa_c{at}ukw.de
Citation
O-(2-(18F)fluoroethyl)-L-tyrosine PET for the differentiation of tumour recurrence from late pseudoprogression in glioblastoma
Publication history
- Received August 31, 2017
- Revised February 27, 2018
- Accepted April 3, 2018
- First published April 28, 2018.
Online issue publication
January 27, 2020
Article Versions
- Previous version (16 January 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.